Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“where its estimated prevalence ranges from 40% to 60% [4,5,6]”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [6]
In the citing paper
“Numerous studies have identified Sc as an independent risk factor for worse postoperative outcomes, reduced tolerance to therapy, and decreased survival in LC patients [4,5,6,7,8].”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [6]
In the citing paper
“CT stands out as the gold standard for muscle mass evaluation, typically performed at the third lumbar vertebra (L3).”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 3×
“As the TUG is a well validated objective measure of physical performance [13], we chose to further explore this measure as a continuous variable.”
BackgroundMethodEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 2×
“The term sarcopenia was first popularized in a study by Baumgartner et al. to describe age-related Oncotarget33659www.impactjournals.com/oncotarget muscle mass loss seen in older adults in New Mexico [4].”
BackgroundFielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 2×
“Although muscle mass does play a role in strength and performance, changes in lean mass only explain a small portion of variability of strength decline (~5%) and attenuation values of muscle on CT appear to account for differences in muscle strength not attributed to muscle quantity [6, 16].”
BackgroundMeasuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 2×
“Additional proposed clinical criteria for diagnosing sarcopenia developed since that time also highlight the importance of muscle weakness and poor physical function, and explicitly recommend against the use of reduced muscle mass alone [8, 9].”
BackgroundMethodMourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 1×
“Consistent methods for utilizing CT imaging to achieve practical and precise measurements of body composition exist and can be performed clinically without significant resource allocation [3].”
MethodNewman, A. B., Kupelian, V., Visser, M., Simonsick, E. M., Goodpaster, B. H., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., & on Behalf of the Health, A. A. B. C. S. I. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.1.72 · Cited by 1,692
Visser, M., Kritchevsky, S. B., Goodpaster, B. H., Newman, A. B., Nevitt, M., Stamm, E., & Harris, T. B. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50217.x · Cited by 845 · cited 1×
“They also found that reduced muscle attenuation was independently associated with poor lower extremity performance [15].”
BackgroundDelmonico, M. J., Harris, T. B., Lee, J., Visser, M., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Newman, A. B., & for the Health, A. A. B. C. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01140.x · Cited by 819
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
Aubrey, J., Esfandiari, N., Baracos, V. E., Buteau, F. A., Frenette, J., Putman, C. T., & Mazurak, V. C. (2014) · Acta Physiologica · doi:10.1111/apha.12224 · Cited by 720 · cited 1×
“The density of skeletal muscle is inversely related to muscle fat content [30].”
BackgroundDeveloping a cancer‐specific geriatric assessment: A feasibility study
Hurria, A., Gupta, S., Zauderer, M., Zuckerman, E. L., Cohen, H. J., Muss, H., Rodin, M., Panageas, K. S., Holland, J. C., Saltz, L., et al. (2005) · Cancer · doi:10.1002/cncr.21422 · Cited by 623
Self-citation
Research works printed but not linked: 21
- Nishijima, 2016, Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review, Eur J Cancer, 57, 58, 10.1016/j.ejca.2015.12.030 · DOI · Paper page
- Levin, 2016, The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature, Oncologist
- Zamboni, 2010, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing, 39, 412, 10.1093/ageing/afq034 · DOI · Paper page
- Kalantar-Zadeh, 2014, Muscle wasting disease: a proposal for a new disease classification, J Cachexia Sarcopenia Muscle, 5, 1, 10.1007/s13539-014-0135-0 · DOI · Paper page
- Anker, 2011, Myopenia-a new universal term for muscle wasting, J Cachexia Sarcopenia Muscle, 2, 1, 10.1007/s13539-011-0025-7 · DOI · Paper page
- Baracos, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
- Harris, 2005, Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons, J Gerontol A Biol Sci Med Sci, 60, 324, 10.1093/gerona/60.3.324 · DOI · Paper page
- Newman, 2001, Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study, J Appl Physiol, 90, 2157, 10.1152/jappl.2001.90.6.2157 · DOI · Paper page
- Harris, 2006, Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort, J Gerontol A Biol Sci Med Sci, 61, 72, 10.1093/gerona/61.1.72 · DOI · Paper page
- Baracos, 2013, Understanding the mechanisms and treatment options in cancer cachexia, Nature Reviews Clinical Oncology, 10, 90, 10.1038/nrclinonc.2012.209 · DOI · Paper page
- Baracos, 2016, Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes, Semin Cell Dev Biol, 54, 2, 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
- Andrykowski, 2008, Physical and psychological long-term and late effects of cancer, Cancer, 112, 2577, 10.1002/cncr.23448 · DOI · Paper page
- Muss, 2014, Feasibility of geriatric assessment in community oncology clinics, J Geriatr Oncol, 5, 245, 10.1016/j.jgo.2014.03.001 · DOI
- Burchenal, 1948, The clinical evaluation of chemotherapeutic agents in cancer, in macleod CM: evaluation of chemotherapeutic agents, 191
- Smyer, 1981, The development, validity, and reliability of the oars multidimensional functional assessment questionnaire, Journals of Gerontology, 36, 428, 10.1093/geronj/36.4.428 · DOI · Paper page
- Reuben, 2001, Geriatric syndromes and assessment in older cancer patients, Oncology (Williston Park), 15, 1567
- Muss, 2015, Geriatric assessment-identified deficits in older cancer patients with normal performance status, Oncologist, 20, 379, 10.1634/theoncologist.2014-0247 · DOI · Paper page
- Baracos, 2009, Automated segmentation of muscle and adipose tissue on CT images for human body composition analysis. in SPIE Medical Imaging, International Society for Optics and Photonics
- Jagersand, 2016, Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle, IEEE Trans Med Imaging, 35, 512, 10.1109/TMI.2015.2479252 · DOI · Paper page
- Muss, 2016, Characterization of skeletal muscle and body mass indices in younger and older women with stage II and III breast cancer, J Am Geriatr Soc, S86
- Muss, 2017, Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane based chemotherapy, Clin Cancer Res, 23, 658, 10.1158/1078-0432.CCR-16-0940 · DOI · Paper page
Cited by
Derstine, B. A., Holcombe, S. A., Ross, B. E., Wang, N. C., Su, G. L., & Wang, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-29825-5 · Cited by 507
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
Aleixo, G. F. P., Shachar, S. S., Nyrop, K. A., Muss, H. B., Malpica, L., & Williams, G. R. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102839 · Cited by 345
Self-citationBozzetti, F. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx271 · Cited by 323
Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., et al. (2025) · Cancers · doi:10.3390/cancers17193255 · Cited by 7
Metadata
- Authors
- Williams, G. R., Deal, A. M., Muss, H. B., Weinberg, M. S., Sanoff, H. K., Nyrop, K. A., Pergolotti, M., & Shachar, S. S.
- Affiliations
- The University of Alabama at Birmingham, Birmingham, AL, USA
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
- The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-04-05
- Volume
- 8
- Issue
- 20
- Pages
- 33658-33665
- ISSN
- 1949-2553
- Cited by
- 107
- References
- 12
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.